Literature DB >> 26669740

Predictors of Outcome in Pediatric Osteomyelitis: Five Years Experience in a Single Tertiary Center.

Andrew C Martin1, Denise Anderson, Julie Lucey, Robin Guttinger, Peter A Jacoby, Tabitha J Mok, Timothy J Whitmore, Colin N Whitewood, David P Burgner, Christopher C Blyth.   

Abstract

BACKGROUND: Acute haematogenous osteomyelitis is a bacterial infection of bone, which occurs most frequently in children. Outcomes are excellent for the majority of children, but a minority develop complicated osteomyelitis. Predicting which children will develop complicated osteomyelitis remains a challenge, particularly in developed countries where most patients are discharged home after a relatively short period in hospital.
METHODS: We conducted a 5-year retrospective case note review of all children aged 3 months to 16 years admitted with a diagnosis of acute haematogenous osteomyelitis. We compared standardized clinical and laboratory parameters in those who developed simple and complicated osteomyelitis.
RESULTS: Of the 299 children who met inclusion, 241 (80.6%) had simple and 58 (19.4%) had complicated osteomyelitis. The major predictors of complicated disease were older age, a temperature greater than 38.5°C and a higher C-reactive protein at admission.
CONCLUSIONS: A risk prediction model, utilizing information available shortly after hospitalization, allows early identification of children at greatest risk of developing complicated osteomyelitis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26669740     DOI: 10.1097/INF.0000000000001031

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  8 in total

1.  [Acute haematogenous osteomyelitis in children : Diagnostic algorithm and treatment strategies].

Authors:  M Willegger; A Kolb; R Windhager; C Chiari
Journal:  Orthopade       Date:  2017-06       Impact factor: 1.087

Review 2.  A Journey into Animal Models of Human Osteomyelitis: A Review.

Authors:  Gabriele Meroni; Alexios Tsikopoulos; Konstantinos Tsikopoulos; Francesca Allemanno; Piera Anna Martino; Joel Fernando Soares Filipe
Journal:  Microorganisms       Date:  2022-05-31

3.  The role of real-time PCR testing in the investigation of paediatric patients with community-onset osteomyelitis and septic arthritis.

Authors:  Sadhbh O'Rourke; Mary Meehan; Désirée Bennett; Nicola O'Sullivan; Robert Cunney; Patrick Gavin; Roisin McNamara; Noelle Cassidy; Stephanie Ryan; Kathryn Harris; Richard Drew
Journal:  Ir J Med Sci       Date:  2019-01-31       Impact factor: 1.568

Review 4.  A Case of Acute Osteomyelitis: An Update on Diagnosis and Treatment.

Authors:  Elena Chiappini; Greta Mastrangelo; Simone Lazzeri
Journal:  Int J Environ Res Public Health       Date:  2016-05-27       Impact factor: 3.390

5.  Epidemiology and Management of Acute Haematogenous Osteomyelitis in a Tertiary Paediatric Center.

Authors:  Elena Chiappini; Caterina Camposampiero; Simone Lazzeri; Giuseppe Indolfi; Maurizio De Martino; Luisa Galli
Journal:  Int J Environ Res Public Health       Date:  2017-05-04       Impact factor: 3.390

6.  SToP (See, Treat, Prevent) skin sores and scabies trial: study protocol for a cluster randomised, stepped-wedge trial for skin disease control in remote Western Australia.

Authors:  Marianne J Mullane; Timothy C Barnett; Jeffrey W Cannon; Jonathan R Carapetis; Ray Christophers; Juli Coffin; Mark A Jones; Julie A Marsh; Frieda Mc Loughlin; Vicki O'Donnell; Rebecca Pavlos; Bec Smith; Andrew C Steer; Steven Y C Tong; Roz Walker; Asha C Bowen
Journal:  BMJ Open       Date:  2019-09-24       Impact factor: 2.692

7.  Prediction of Adverse Outcomes in Pediatric Acute Hematogenous Osteomyelitis.

Authors:  Zaid Alhinai; Morvarid Elahi; Sangshin Park; Bill Foo; Brian Lee; Kimberle Chapin; Michael Koster; Pablo J Sánchez; Ian C Michelow
Journal:  Clin Infect Dis       Date:  2020-12-03       Impact factor: 9.079

Review 8.  Update on the Management of Pediatric Acute Osteomyelitis and Septic Arthritis.

Authors:  Luca Castellazzi; Marco Mantero; Susanna Esposito
Journal:  Int J Mol Sci       Date:  2016-06-01       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.